Page last updated: 2024-10-24

cefuroxime and Lupus Erythematosus, Cutaneous

cefuroxime has been researched along with Lupus Erythematosus, Cutaneous in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rudnicka, L1
Szymańska, E1
Walecka, I1
Słowińska, M1

Other Studies

1 other study available for cefuroxime and Lupus Erythematosus, Cutaneous

ArticleYear
Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases.
    Dermatology (Basel, Switzerland), 2000, Volume: 200, Issue:2

    Topics: Adult; Cefuroxime; Cephalosporins; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Skin

2000